How can biosimilars change the trajectory of breast cancer therapy?

被引：9

作者：

Trapani, Dario ^{[1
,2
]}

Curigliano, Giuseppe ^{[1
,2
]}

机构：

[1] European Inst Oncol IRCCS, Div Early Drug Dev Innovat Therapies, Milan, Italy

[2] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2020年 / 20卷 / 05期

关键词：

Biosimilars; breast cancer; trastuzumab; similar biotherapeutic products; SBP; UHC; cancer policy; TRASTUZUMAB;

D O I：

10.1080/14737140.2020.1757438

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：325 / 328

页数：4

共 15 条

[1]

[Anonymous], 2019, Global Health Observatory

[2]

[Anonymous], 2023, Sustainable Development Goals

[3] Biosimilars: Extrapolation for oncology [J].

Curigliano, Giuseppe ;

O'Connor, Darran P. ;

Rosenberg, Julie A. ;

Jacobs, Ira .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 104 :131-137

[4]

Fullman N, 2017, LANCET, V390, P1423, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]

[5] Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders [J].

Jarvis, Jordan D. ;

Murphy, Adrianna ;

Perel, Pablo ;

Persaud, Nav .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (40) :E1093-E1099

[6] Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+breast cancer [J].

Lammers, Philip E. ;

Dank, Magdolna ;

Masetti, Riccardo ;

Abbas, Richat ;

Hilton, Fiona ;

Coppola, Jennifer ;

Jacobs, Ira .

BRITISH JOURNAL OF CANCER, 2018, 119 (03) :266-273

[7] PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study [J].

Pegram, Mark D. ;

Bondarenko, Igor ;

Costa Zorzetto, Marina Moreira ;

Hingmire, Sachin ;

Iwase, Hirotaka ;

Krivorotko, Petr V. ;

Lee, Keun Seok ;

Li, Rubi K. ;

Pikiel, Joanna ;

Aggarwal, Rajesh ;

Ewesuedo, Reginald ;

Freyman, Amy ;

Li, Ray ;

Vana, Alicia ;

Yin, Donghua ;

Zacharchuk, Charles ;

Tan-Chiu, Elizabeth .

BRITISH JOURNAL OF CANCER, 2019, 120 (02) :172-182

[8] Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer [J].

Pivot, Xavier ;

Bondarenko, Igor ;

Nowecki, Zbigniew ;

Dvorkin, Mikhail ;

Trishkina, Ekaterina ;

Ahn, Jin-Hee ;

Vinnyk, Yuriy ;

Im, Seock-Ah ;

Sarosiek, Tomasz ;

Chatterjee, Sanjoy ;

Wojtukiewicz, Marek Z. ;

Moiseyenko, Vladimir ;

Shparyk, Yaroslav ;

Bello, Maximino, III ;

Semiglazov, Vladimir ;

Song, Sujeong ;

Lim, Jaeyun .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (10) :968-+

[9] Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care [J].

Pramesh, C. S. ;

Chaturvedi, Harit ;

Reddy, Vijay Anand ;

Saikia, Tapan ;

Ghoshal, Sushmita ;

Pandit, Mrinalini ;

Babu, K. Govind ;

Ganpathy, K., V ;

Savant, Dhairyasheel ;

Mitera, Gunita ;

Sullivan, Richard ;

Booth, Christopher M. .

LANCET ONCOLOGY, 2019, 20 (04) :E218-E223

[10] Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer A Randomized Clinical Trial [J].

Rugo, Hope S. ;

Barve, Abhijit ;

Waller, Cornelius F. ;

Hernandez-Bronchud, Miguel ;

Herson, Jay ;

Yuan, Jinyu ;

Sharma, Rajiv ;

Baczkowski, Mark ;

Kothekar, Mudgal ;

Loganathan, Subramanian ;

Manikhas, Alexey ;

Bondarenko, Igor ;

Mukhametshina, Guzel ;

Nemsadze, Gia ;

Parra, Joseph D. ;

Abesamis-Tiambeng, Maria Luisa T. ;

Baramidze, Kakhaber ;

Akewanlop, Charuwan ;

Vynnychenko, Ihor ;

Sriuranpong, Virote ;

Mamillapalli, Gopichand ;

Ray, Sirshendu ;

Yanez Ruiz, Eduardo P. ;

Pennella, Eduardo .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01) :37-47

← 1 2 →